Literature DB >> 9549455

Survival rates from interval cancer in NHS breast screening programme.

S Collins1, C B Woodman, A Threlfall, P Prior.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9549455      PMCID： PMC28488          DOI： 10.1136/bmj.316.7134.832

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme.

Authors:  N Day; J McCann; C Camilleri-Ferrante; P Britton; G Hurst; S Cush; S Duffy
Journal:  J Med Screen       Date:  1995       Impact factor: 2.136

2.  A computer program package for relative survival analysis.

Authors:  T Hakulinen; K H Abeywickrama
Journal:  Comput Programs Biomed       Date:  1985

3.  Update of the Swedish two-county program of mammographic screening for breast cancer.

Authors:  L Tabàr; G Fagerberg; S W Duffy; N E Day; A Gad; O Gröntoft
Journal:  Radiol Clin North Am       Date:  1992-01       Impact factor: 2.303

4.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15

5.  Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region.

Authors:  C B Woodman; A G Threlfall; C R Boggis; P Prior
Journal:  BMJ       Date:  1995-01-28
  5 in total
  4 in total

1.  High expression of the trefoil protein TFF1 in interval breast cancers.

Authors:  M Crosier; D Scott; R G Wilson; C D Griffiths; F E May; B R Westley
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  A study of interval breast cancer within the NHS breast screening programme.

Authors:  W K Cowan; B Angus; J C Gray; L G Lunt; S R al-Tamimi
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

3.  Prognosis in women with interval breast cancer: population based observational cohort study.

Authors:  Mette Kalager; Rulla M Tamimi; Michael Bretthauer; Hans-Olov Adami
Journal:  BMJ       Date:  2012-11-16

4.  Are international differences in breast cancer survival between Australia and the UK present amongst both screen-detected women and non-screen-detected women? survival estimates for women diagnosed in West Midlands and New South Wales 1997-2006.

Authors:  Laura M Woods; Bernard Rachet; Dianne L O'Connell; Gill Lawrence; Michel P Coleman
Journal:  Int J Cancer       Date:  2016-02-23       Impact factor: 7.396
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.